Circulating sRANKL, Periostin, and Osteopontin as Biomarkers for the Assessment of Activated Osteoclastogenesis in Myeloma Related Bone Disease.

Gerov, Vladimir; Gerova, Daniela; Micheva, Ilina; Nikolova, Miglena; Pasheva, Milena; Nazifova, Neshe; Galunska, Bistra

Gerov, Vladimir; Gerova, Daniela; Micheva, Ilina; Nikolova, Miglena; Pasheva, Milena; Nazifova, Neshe; Galunska, Bistra.

Afiliación

Gerov V; Clinics of Hematology, "St. Marina" University Hospital, 9010 Varna, Bulgaria.
Gerova D; Department of Clinical Laboratory, Faculty of Medicine, MU Varna, 9002 Varna, Bulgaria.
Micheva I; Clinics of Hematology, "St. Marina" University Hospital, 9010 Varna, Bulgaria.
Nikolova M; Second Department of Internal Disease, Faculty of Medicine, MU Varna, 9002 Varna, Bulgaria.
Pasheva M; Department of Biochemistry, Molecular Medicine and Nutrigenomics, Faculty of Pharmacy, MU Varna, 9000 Varna, Bulgaria.
Nazifova N; Department of Biochemistry, Molecular Medicine and Nutrigenomics, Faculty of Pharmacy, MU Varna, 9000 Varna, Bulgaria.
Galunska B; Department of Biochemistry, Molecular Medicine and Nutrigenomics, Faculty of Pharmacy, MU Varna, 9000 Varna, Bulgaria.

Cancers (Basel) ; 15(23)2023 Nov 24.

Article en En | MEDLINE | ID: mdl-38067265

Palabras clave

biomarkers; myeloma bone disease; osteopontin; periostin; sRANKL

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Cancers (Basel) Año: 2023 Tipo del documento: Article País de afiliación: Bulgaria Pais de publicación: Suiza

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google